LncRNA SNHG7 promotes non-small cell lung cancer progression and cisplatin resistance by inducing autophagic activity

BACKGROUND: Cisplatin (DDP) is among the most widely used chemotherapeutic drugs for non-small cell lung cancer (NSCLC), yet the frequent emergence of chemoresistance serves as a major barrier to the treatment of this tumor type. Long non-coding RNAs (lncRNAs) have recently been shown to influence t...

Descripción completa

Detalles Bibliográficos
Autores principales: She, Kelin, He, Shushuai, Lu, Xiao, Yu, Shaoqi, Li, Mengna, Xiong, Wei, Zhou, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922599/
https://www.ncbi.nlm.nih.gov/pubmed/36794139
http://dx.doi.org/10.21037/jtd-22-1826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922599/
https://www.ncbi.nlm.nih.gov/pubmed/36794139
http://dx.doi.org/10.21037/jtd-22-1826

Ejemplares similares